Fig. 4
From: Pyroglutamate and Isoaspartate modified Amyloid-Beta in ageing and Alzheimer’s disease

Correlation analysis. Representation of the most significant correlations (p < 0.01) observed in the AD, OC and YC cohorts
From: Pyroglutamate and Isoaspartate modified Amyloid-Beta in ageing and Alzheimer’s disease
Correlation analysis. Representation of the most significant correlations (p < 0.01) observed in the AD, OC and YC cohorts